Femannose N Plv 60 Btl 4 g
Femannose N Plv 60 Btl 4 g
-
126.63 USD
Sie sparen 0 / 0%
Kaufen Sie 2 und sparen Sie 32.27 USD / -14%
- Verfügbarkeit Auf Lager
- Vertriebspartner MELISANA AG
- Hersteller Femannose
- Pharmacode 7756720
- EAN 7611136102389
Ingredient:
Beschreibung
For the treatment and prevention of cystitis (inflammation of the bladder) and other urinary tract infections
Compendium patient information
Femannose® N
Medical device
What is Femannose N and when is it used?
Cystitis (inflammation of the bladder) and related diseases are microbial diseases that primarily affect the bladder and urethra. In most cases, they are triggered by the invasion of non-pathogenic bacteria from the microflora of the lower gastrointestinal tract when these bacteria find conditions that allow them to adhere and grow on the bladder wall and urinary tract. These conditions are most common in young women, during pregnancy, and during the peri- and post-menopause, but sometimes in older men or in catheterized patients. The drug therapy of choice for cystitis is currently the administration of antibiotics. However, many bacteria are resistant and can lead to recurrence of the infection. Femannose N is a medical device indicated for the treatment and prevention of cystitis and other uncomplicated lower bacterial urinary tract infections (UTIs). D-Mannose can relieve the most common symptoms of lower urinary tract infections (burning urination, frequent urination, urinary urgency, etc.) when they are caused by bacteria of the Escherichia coli type. D-Mannose is an epimer of glucose that effectively prevents the attachment of pathogens to the epithelium of the urinary tract, thereby preventing the attachment of microbes invading the urogenital tract. This reduces its virulence, or ability to attach to urinary tract tissue, and helps to 'physically' prevent infections from reoccurring. Femannose N for the prevention or treatment of cystitis and other uncomplicated bacterial lower urinary tract infections can have a synergistic effect with antibiotics because the antimicrobial mode of action is different and does not overlap. In particular, Femannose N and its components do not contribute to the development of resistance. Femannose N is not a substitute for antibiotic treatment of urinary tract infections.
When should Femannose N not be used?
Do not use Femannose N if you have a known hypersensitivity such as allergies or intolerance to any of the ingredients . The product must not be used on children under 14 years of age.
When should you be careful when taking Femannose N?Interactions with dietary supplements and medication
There are no known interactions with dietary supplements for the components of Femannose N. However, dietary supplements including vitamins, nutrients, herbal and homeopathic medicines should generally be taken at least two hours before or after using Femannose N. Drug interactions: Concomitant use of Femannose N does not affect the effectiveness of antibiotics. The anti-adhesive effect of D-Mannose does not lead to any resistance. Mannose is not metabolized and therefore has no interaction with other substances.
Can FemannoseN be taken during pregnancy or breastfeeding?
During pregnancy and breastfeeding it is recommended to use the product only after consultation to be used with the doctor.
How do you use Femannose N?
Only use Femannose N after consulting your doctor, pharmacist or druggist , pharmacist or druggist. For adults and children over 14 years old. The following dosage is recommended for the treatment of acute cystitis:
DayNumber of sachets per day |
1. up to day 334. and day 52 |
The recommended dose for prevention of cystitis is one sachet per day . The recommended dosage must not be exceeded! Income should be distributed throughout the day. It is recommended to take the product between meals. Each sachet is intended for single use and should only be opened just before use. Dissolve the contents of one sachet in a glass of water. It is recommended to drink at least two liters of water per day to promote urination. To prevent recurrence of infection, treatment should be continued for a month. If the symptoms have not improved noticeably after three days, you should stop taking it and contact a doctor. Do not take Femannose N for more than 30 days. If symptoms persist, contact a doctor.
What side effects can Femannose N have?
Special tests have shown that the components of Femannose N are harmless, fully biocompatible and well tolerated . At the dosage required for a therapeutic effect, no side effects were found, apart from individual intolerance, which can lead to nausea, flatulence and loose stools. If symptoms persist, contact your health care professional.
What else needs to be considered?Storage
Keep Femannose N in a dry place and away from direct heat and protected from light. Only open the sachet just before use. Store the product below 25°C. Keep out of the reach of children.
Expiry date
Do not take the product after the expiry date printed on the packaging. The expiry date refers to the product stored in the intact packaging.
Disposal
Expired products must be disposed of in accordance with local environmental regulations. Do not dispose of the product and its packaging in the environment.
What does Femannose N contain?
Each sachet contains: 2g D-Mannose. Excipients: Sweeteners: fructose, sucralose; Citric acid; dye: beetroot; release agent: silicon dioxide; Aroma. Vegan.
Where can you get Femannose N? What packs are available?
Available in pharmacies and drugstores. Packages of 14, 30 and 60 sachets of 4.0 g each.
Distribution company
Melisana AG, 8004 Zurich, Switzerland
Status of information
September 2020.
This product is CE-marked. This guarantees that European safety standards are met.